Sanofi Pasteur contracts NatureForm for new flu vaccine facility in Pennsylvania
Sanofi Pasteur, the world’s largest dedicated producer of human vaccines, is to build a state-of-the-art new vaccine production facility with SmartPro™ NF incubation systems at its campus in Swiftwater, Pennsylvania.
With 10 incubators built to exacting pharmaceutical standards, the new facility will have a total incubation capacity of more than 2.5 million eggs and is expected to be operational in 2019.
Sanofi Pasteur produces more than 1 billion doses of vaccine each year and previously expanded its Swiftwater vaccine production capabilities with NatureForm equipment in 2006. Successful project management, validation capabilities and the ability to meet the stringent demands of human vaccine production were key factors in the company’s decision to work with NatureForm Hatchery Technologies again for this new expansion.
SmartPro™ NF incubation allows for precise, zonal temperature control, which delivers more viable embryos and therefore a greater vaccine yield. All incubators will be...
Do you already have an account? Log in here